Quick Takeaways
- This page summarizes Jr. Robert E. Funck's Form 4 filing for ABBOTT LABORATORIES (ABT).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 04 Mar 2024, 19:00.
Jr. Robert E. Funck - 29 Feb 2024 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)
- Signature
- /s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact
- Issuer symbol
- ABT
- Transactions as of
- 29 Feb 2024
- Net transactions value
- -$1,370,371
- Form type
- 4
- Filing time
- 04 Mar 2024, 19:00:37 UTC
- Previous filing
- 23 Feb 2024
- Next filing
- 14 May 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Jr. Robert E. Funck filed Form 4 for ABBOTT LABORATORIES (ABT) on 04 Mar 2024."
What Changed
- Previous filing in this sequence was filed on 23 Feb 2024.
- Current net transaction value: -$1,370,371.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABT | Common shares without par value | Tax liability | $1,370,371 | -11,415 | -5.1% | $120.05 | 211,341 | 29 Feb 2024 | Direct | |
| holding | ABT | Common shares without par value | 20,000 | 29 Feb 2024 | By Trust | F1 | |||||
| holding | ABT | Common shares without par value | 20,000 | 29 Feb 2024 | By Trust | F1 | |||||
| holding | ABT | Common shares without par value | 18,765 | 29 Feb 2024 | Profit Sharing Trust | F2 | |||||
| holding | ABT | Common shares without par value | 500 | 29 Feb 2024 | By Daughter | F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust. |
| F2 | Balance in the Abbott Laboratories Stock Retirement Trust as of March 1, 2024. |
| F3 | The reporting person disclaims beneficial ownership of all securities held by his daughter. |